The minimally-invasive procedure, called thoracoabdominal branch endoprosthesis, addresses aortic aneurysms, life-threatening ...

Abdominal aortic aneurysm (AAA) repair has undergone a remarkable transformation over the last 2 decades, primarily driven by ...

The Penn State Health Milton S. Hershey Medical Center became the first hospital in the Midstate to perform a minimally ...

Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that first quarter 2025 financial results will be released on Monday, May 5, 2025 ...

The Germany Cardiovascular Devices Market is projected to grow by US$ 1.68 billion during the forecast period of 2020-2026, at a robust CAGR of 6.9%. Get a Free Sample PDF copy of the report @- https: ...

The Italy cardiovascular devices market is projected to grow by US$ 777 million during 2020-2026, progressing at a robust CAGR of 6.7% over the forecast period.

With no exemptions for medical devices from Trump’s double-digit tariffs, pacemakers, insulin pumps and hearing aids could ...

Aortic coarctation is a fatal cardiovascular disease. For Stanford type B aortic coarctation, aortic endovascular isolation (TEVAR) is currently the treatment of choice and is far less invasive than ...

The company advised that the Gore TAG conformable thoracic stent graft with Active Control system, which was first approved in 2019, is indicated for endovascular repair of all lesions of the ...

The Group's key products, including congenital heart disease (CHD) occluders, left atrial appendage (LAA) occluders, aortic stent grafts and vena cava filters, continued to develop in depth in the ...

SHENZHEN, China, March 28, 2025 /PRNewswire/ -- LifeTech Scientific Corporation (the "Company" or "LifeTech", Stock code: 1302.HK), a company specializing in minimally invasive interventional ...